|
CN104237407A
|
|
Method for detecting releasing rate of amantadine hydrochloride sustained release tablets
|
|
CN103919746A
|
|
Edoxaban sustained release tablet and preparation method thereof
|
|
CN103743832A
|
|
HPLC (High Performance Liquid Chromatography) measuring method of related substances in Dabigatran
|
|
CN103926335A
|
|
High performance liquid chromatography detection method for related substances in dapoxetine
|
|
CN103919731A
|
|
Preparation of alcohol tolerant venlafaxine hydrochloride sustained-release pellet
|
|
CN103494786A
|
|
Medicinal composition containing moxifloxacin hydrochloride
|
|
CN103592379A
|
|
Analytic method of omeprazole related substance
|
|
CN103479856A
|
|
Rhizoma anemarrhenae chemical component cluster extracts and preparation process thereof
|
|
CN103613581A
|
|
Preparation method for Dexiansoprazole
|
|
CN103417504A
|
|
Novel method for preparing omeprazole sodium bicarbonate magnesium hydrate pill
|
|
CN103405395A
|
|
Sodium picosulfate enteric-coated tablet and preparation method thereof
|
|
CN103385878A
|
|
Repaglinide and dimethyldiguanide pharmaceutical composition and preparation method thereof
|
|
CN103364502A
|
|
High performance liquid chromatography (HPLC) determination method for related substances in difluprednate
|
|
CN103353494A
|
|
HPLC (high performance liquid chromatography) detection method of related substances in almotriptan malate
|
|
CN103193726A
|
|
Method for synthesizing moguisteine active metabolite
|
|
CN103086957A
|
|
Method for preparing high purity sodium picosulfate
|
|
CN103086954A
|
|
Method for preparing ropivacaine
|
|
CN103086875A
|
|
Synthetic method of felbinac non-steroidal anti-inflammatory agent
|
|
CN103113443A
|
|
Novel chemical synthesis method for preparing mecobalamine
|
|
CN103049662A
|
|
Application method of response surface analysis to Chinese herbal compound studies
|
